EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Low-virulence bacteria and intervertebral disc degeneration: evidence, causality, and clinical implications

Yongjun Tong, Xiangxi Kong, Simeng Jin, Junhui Liu, Bao Huang, Jian Chen, Fengdong Zhao

Frontiers in Medicine · 18.11.2026 · 13

DOI: 10.3389/fmed.2026.2011983 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Medicine, online erschienen am 18.11.2026. Verfasst von Yongjun Tong und 6 weiteren Autor:innen. Die Arbeit nennt 81 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Whether low-virulence bacteria contribute to intervertebral disc degeneration remains uncertain. This narrative review examines human microbiological findings, antibiotic trials, animal models, and mechanistic studies, to distinguish evidence of infection from colonization or contamination. Cutibacterium acnes ( C. acnes ) is the organism studied most extensively. Culture, polymerase chain reaction, histology, fluorescence in situ hybridization, and immunohistochemistry have detected bacteria or bacterial components in some human discs. However, results vary and are difficult to interpret in low-biomass specimens vulnerable to contamination. Intracellular bacterial signals do not establish host-cell identity or the presence of viable organisms. Human studies have not established whether bacterial entry precedes degeneration. In experimental models, C. acnes can induce inflammation, cell loss, matrix degradation, and endplate or marrow injury, but direct inoculation and procedural injury limit extrapolation to human disease. Antibiotic trials have yielded mixed results. Low-certainty evidence suggests slight pain relief and small-to-moderate improvement in disability at 12–14 weeks with oral antibiotics in patients with Modic type 1 changes and disc herniation. These findings do not establish a basis for routine prolonged treatment. Trials did not require microbiological confirmation of intradiscal infection, so any benefit cannot be attributed specifically to treatment of infection. Current evidence does not justify routine prolonged empirical treatment based solely on Modic changes or a single positive culture. The “damage–infection–accelerated degeneration” and transient “hit-and-run” models remain hypotheses without longitudinal human confirmation. Animal culture-negative endpoints do not establish bacterial eradication or continued degeneration after clearance. Longitudinal studies should examine the sequence of barrier injury, bacterial entry, and degeneration using contamination-controlled assessments of microbial viability, tissue localization, and host response. Host-response markers require validation before use in patient selection.

Zitieren

APA

Tong, Y., Kong, X., Jin, S., Liu, J., Huang, B., Chen, J., & Zhao, F. (2026). Low-virulence bacteria and intervertebral disc degeneration: evidence, causality, and clinical implications. Frontiers in Medicine, 13. https://doi.org/10.3389/fmed.2026.2011983

Vancouver

Tong Y, Kong X, Jin S, Liu J, Huang B, Chen J, et al. Low-virulence bacteria and intervertebral disc degeneration: evidence, causality, and clinical implications. Frontiers in Medicine. 2026;13. doi:10.3389/fmed.2026.2011983

BibTeX
@article{Tong2026,
  author = {Tong, Yongjun and Kong, Xiangxi and Jin, Simeng and Liu, Junhui and Huang, Bao and Chen, Jian and Zhao, Fengdong},
  title = {Low-virulence bacteria and intervertebral disc degeneration: evidence, causality, and clinical implications},
  journal = {Frontiers in Medicine},
  year = {2026},
  volume = {13},
  doi = {10.3389/fmed.2026.2011983}
}
Kostenlos starten →